DEVICE CATEGORY · QUE
Spinal Muscular Atrophy Newborn Screening Test System
A Spinal Muscular Atrophy (SMA) newborn screening test system is a prescription device intended to detect homozygous deletion of exon 7 or other similar mutations in the SMN1 (Survival Motor Neuron 1) gene of DNA obtained from dried blood spot specimens on filter paper using a polymerase chain reaction-based test as an aid in screening newborns for SMA. Presumptive positive results are intended to be followed up by diagnostic confirmatory testing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Eonis SMA kitK262893 | Revvity, Inc. | 510(k) clearance | Sep 30, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
